Latest Licensing News

Page 1 of 186
Aguia Resources has sold 825 tonnes of Pampafos since 15 September while a 30,000-tonne ore stockpile awaits processing. The progress comes as the company faces an unresolved court challenge to its Tres Estradas phosphate project and begins permitting work at Passo Feio.
Maxwell Dee
Maxwell Dee
8 Oct 2026
Environmental Clean Technologies has confirmed MXene formation in two preliminary Flash Joule Heating runs, moving its US-focused programme from laboratory theory to physical product. The harder commercial tests remain ahead: repeatability, customer qualification, scale-up and shareholder approval for the Xenica acquisition and second placement tranche.
Victor Sage
Victor Sage
8 Oct 2026
Zinc of Ireland has secured firm commitments for a $3.2 million placement to fund ARGO critical-mineral recovery work, VOLTA battery-recycling development and drilling at Kildare. The raise gives the company a defined execution schedule, but adds 180 million new shares before several commercial milestones remain unproven.
Victor Sage
Victor Sage
8 Oct 2026
Cynata Therapeutics has launched a fully underwritten $913,000 entitlement offer as it reassesses the future of its Cymerus platform after two major trials failed to demonstrate efficacy. The raise provides short-term funding, but the prospectus warns that further capital may be needed and repeats a material uncertainty over going concern.
Ada Torres
Ada Torres
8 Oct 2026
InFocus is extending its Codexa platform from US sweepstakes gaming into licensed real-money online gambling markets, initially targeting Curaçao and crypto-native operators. Commercial availability is expected in early 2027, but the expansion still depends on product testing, regulatory registration and customer uptake.
Sophie Babbage
Sophie Babbage
8 Oct 2026
PC Gold will acquire the last third-party mining leases inside its Spring Hill development area, adding a water licence and operating rights for A$6.5 million. The deal could simplify mine planning and approvals, but still requires Northern Territory ministerial approval and does not add a reported resource.
Maxwell Dee
Maxwell Dee
8 Oct 2026
Sigma Lithium says a Federal Court of Appeals decision has restored the environmental licences supporting its Grota do Cirilo operation, allowing mining and processing to resume. The company has also reaffirmed its target of reaching 330,000 tonnes of annualised lithium oxide concentrate production by year-end 2027.
Maxwell Dee
Maxwell Dee
7 Oct 2026
Yowie Group’s FY26 loss narrowed sharply after cost reductions and a non-cash loan impairment reversal, but revenue fell 27% and operating cash flow turned deeply negative. The confectionery maker remains loss-making, has negative net assets and faces uncertainty over funding, supply and the return of its ASX quotation.
Victor Sage
Victor Sage
6 Oct 2026
dorsaVi has secured A$3.0 million to expand its movement-data business for humanoid robotics while advancing its neuromorphic and RRAM chip programs. The raise comes as its first RRAM-CMOS validation chip moves into proprietary memory integration at TSMC.
Sophie Babbage
Sophie Babbage
6 Oct 2026
Aquirian has completed its Wubin Energetics Hub upgrade within budget and is preparing Drillforce to begin work at Brightstar Resources’ Lord Byron project under a contract valued at approximately $48 million over three years. The company also says Collar Keeper sales remain strong, while a biodegradable version moves towards commercialisation.
Victor Sage
Victor Sage
6 Oct 2026
HealthCo Healthcare and Wellness REIT has signed binding agreements for new leases covering its remaining 10 Healthscope hospitals, subject to final approvals. The resolution allows HCW to reinstate quarterly distributions while reducing its largest tenant concentration from 57% to 31%.
Eva Park
Eva Park
5 Oct 2026
LTR Pharma has completed the final Phase II pharmacokinetic report for SPONTAN, confirming a median 10-minute time to peak concentration against 60 minutes for an oral vardenafil tablet. The result completes the FDA-aligned dataset ahead of planned US submission work, although efficacy in erectile dysfunction patients remains to be tested.
Victor Sage
Victor Sage
1 Oct 2026

Browse the archive

Full archive